Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
1.950
+0.010 (0.52%)
At close: Jan 30, 2026, 4:00 PM EST
1.980
+0.030 (1.54%)
After-hours: Jan 30, 2026, 5:17 PM EST
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $246.29 million as of January 30, 2026. Its market cap has increased by 5.46% in one year.
Market Cap
246.29M
Enterprise Value
141.87M
1-Year Change
5.46%
Ranking
Category
Stock Price
$1.95
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $246.29M, an increase of 110.44%. That is a compound annual growth rate of 16.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 245.03M | -0.51% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | 117.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relmada Therapeutics | 264.00M |
| OmniAb | 262.72M |
| Fennec Pharmaceuticals | 255.81M |
| Cabaletta Bio | 253.18M |
| Armata Pharmaceuticals | 249.02M |
| Context Therapeutics | 247.61M |
| Shattuck Labs | 246.47M |
| Heron Therapeutics | 243.87M |